Friberget et al. first reported the IDO1 pathway as a possible tumor immune escape mechanism in 2002 when they observed IDO1 expression by monocytes in tumor tissues and tumor-draining lymph nodes [67]. This evidence concerns the gene IDO1 and neoplasm.